Orbimed Advisors Trims $125 After Breakout Year in Biotech
A major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
Tracking error measures how closely an index fund follows its benchmark. Grasp its implications to evaluate fund tracking accuracy.
14,431 articlesA major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
A major institutional move grabs attention as landmark investment partners cuts its stake in Howard Hughes Holdings. ...
A Ukrainian national pleaded guilty in a high-profile Conti ransomware case, highlighting the financial risks of cybe...
Sensational headlines can tug at your wallet. This guide shows you how to separate rumor from reality, vet financial ...
A notable fund pulled out of a multi-million dollar DNOW position last quarter, triggering questions about strategy a...
Retirees are weighing 401(K) rollovers to traditional IRAs as SECURE 2.0 tweaks and market volatility shift retiremen...
Looking to build a global core sleeve for your portfolio? This guide compares Vanguard Total World Stock and VWO, exp...
A high-stakes media merger is drawing political attention and investor caution. Eight Senate Democrats are pressing D...
When a once-heroic role sparks threats and backlash, it isn’t only the emotions that suffer. The financial ripple can...
President Trump’s push for a temporary gas tax pause highlights a deeper funding crisis for roads and bridges. Expert...
As the 2026 COLA lands at 2.8%, retirees face a growing gap between checks and living costs. A disciplined four-ETF i...
Fintech is reshaping how we invest and borrow, but rapid tech, crypto, and AI bring new risks. This guide distills ex...